Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
European Journal of Pharmacology|May 15, 1993
Modelling and modification of the binding site of endothelin and other receptorsJ P Huggins, S Trumpp-Kallmeyer, M F Hibert, et al.European Journal of Pharmacology|October 8, 1999
Site-directed mutagenesis of the putative human muscarinic M2 receptor binding siteF Heitz, J A Holzwarth, J P Gies, et al.Drug Design and Discovery|December 1, 1996
Three-dimensional molecular models of the hMC1R melanocortin receptor: complexes with melanotropin peptide agonistsC Haskell-Luevano, T K Sawyer, S Trumpp-Kallmeyer, et al.The Journal of Biological Chemistry|October 27, 1995
The binding site of neuropeptide vasopressin V1a receptor. Evidence for a major localization within transmembrane regionsB Mouillac, B Chini, M N Balestre, et al.Journal of Receptor and Signal Transduction Research|March 11, 1999
Functional architecture of vasopressin/oxytocin receptorsM Hibert, J Hoflack, S Trumpp-Kallmeyer, et al.Advances in Experimental Medicine and Biology|January 1, 1995
Identification of agonist binding sites of vasopressin and oxytocin receptorsB Mouillac, B Chini, M N Balestre, et al.The EMBO Journal|May 15, 1995
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptorB Chini, B Mouillac, Y Ala, et al.FEBS Letters|November 18, 1996
Two aromatic residues regulate the response of the human oxytocin receptor to the partial agonist arginine vasopressinB Chini, B Mouillac, M N Balestre, et al.Advances in Experimental Medicine and Biology|January 1, 1995
Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor familyB Chini, B Mouillac, Y Ala, et al.Journal of Medicinal Chemistry|July 8, 1999
Structure-activity relationships for 5-substituted 1-phenylbenzimidazoles as selective inhibitors of the platelet-derived growth factor receptorB D Palmer, A J Kraker, B G Hartl, et al.Pageof 3